Historical record - last NADAC effective date: 4/17/2024
Product Information
OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.2019 per EA under NDC 43386049301. Its NADAC has been published 217 times since Mar 25, 2020.
FDA first approved this application on Feb 24, 2017. Its Orange Book therapeutic-equivalence code is AA.
Strength
325; 10 mg/1; mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
43386049301
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
4/17/2024
Active Ingredients
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204407FDA Approved
2/24/2017
TE Code
AA
On Market Since
2/24/2017
Pharmacological Classes
Price Statistics
The NADAC for OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET has been published 217 times since Mar 25, 2020, and over the history we have for it it has declined 25.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2019 per EA |
|---|---|
| All-time high | $0.2709 (Apr 15, 2020) |
| All-time low | $0.1580 (Sep 22, 2021) |
| Median price | $0.1980 |
| Average price | $0.1983 |
| Largest weekly change | -18.7% (Jun 22, 2022) |
| Weeks tracked | 217 |
| Tracking since | Mar 25, 2020 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-2.0%
5Y
+13.6%
All
-25.5%
Last surveyed May 15, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.2019 per EA (NDC 43386049301), effective May 15, 2024.
How has the price of OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET has declined 25.5%. It has been tracked across 217 weekly CMS publications since Mar 25, 2020.
What are the highest and lowest recorded NADAC prices for OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET?
Since Mar 25, 2020, the NADAC for OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET has ranged from a low of $0.1580 (Sep 22, 2021) to a high of $0.2709 (Apr 15, 2020), with a median of $0.1980 per EA.
Are there cheaper alternatives to OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET?
Yes. 12 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET, is $0.1796 per EA — about 11% below OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET.
Who manufactures OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET?
OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET (NDC 43386049301) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.